EpiPen is Just a Symptom of the Big Pharma Disease

by Sydney Robinson | Aug 29, 2016 | Pharmaceutical Industry |

Valeant Pharmaceuticals, “Pharma Bro” Martin Shkreli, and now Mylan and the EpiPen – on their own,...

In the UK, They Regulate – In the US, We Litigate: the Failures of the FDA

by Sydney Robinson | Aug 8, 2016 | Pharmaceutical Industry |

American and European regulatory systems differ by one major principal: In the U.K., if a product...

Big Pharma Price Gouges on Heroin Overdose Medicine

by Sydney Robinson | Jun 7, 2016 | Pharmaceutical Industry |

Amidst a growing opioid epidemic across the nation, big pharma is seeing dollar signs and an...

The House Refuses to Pass Legislation Preventing Drug Price-Gouging

by Sydney Robinson | Apr 28, 2016 | Pharmaceutical Industry |

It’s a heartwarming bipartisan issue in the House as both Democrat and Republican...

Pfizer Drops $150 Billion Proposed Merger after Obama Cracks Down on Corporate Inversion

by Mollye Barrows | Apr 7, 2016 | Pharmaceutical Industry |

The biggest drug company in the U.S. won’t be moving to Ireland after all. Pfizer dropped the $150...

Obama Stops Big Pharma’s Tax Dodging Scheme

by Sydney Robinson | Apr 6, 2016 | Pharmaceutical Industry |

In mid-March, senator Bernie Sanders sent a letter to the secretary of the treasury, Jack Lew,...